| Dr Timothy R Jones, MD | |
|
1673 Mason Ave, Suite #305, Daytona Beach, FL 32117-5515 | |
| (386) 274-7118 | |
| (386) 274-6173 |
| Full Name | Dr Timothy R Jones |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 27 Years |
| Location | 1673 Mason Ave, Daytona Beach, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154358398 | NPI | - | NPPES |
| 15620 | Other | FL | BLUE CROSS BLUE SHIELD |
| 264629300 | Medicaid | FL |
| Facility Name | Location | Facility Type |
|---|---|---|
| Flagler Hospital | Saint augustine, FL | Hospital |
| Halifax Health Medical Center | Daytona beach, FL | Hospital |
| Halifax Health /uf Health Medical Center Of Delton | Deltona, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Radiology Imaging Associates, Llc | 2466342803 | 74 |
| Inverness Medical Imaging Llc | 3870590672 | 66 |
| East Central Florida Outpatient Imaging Llc | 9830175199 | 39 |
News Archive
A webcam language interpretation service is helping three Arizona hospitals better serve Spanish-speaking patients in their emergency departments, the East Valley & Scottsdale Tribune reports. The Iasis Healthcare hospitals had relied on telephone interpretation services before implementing the new webcam system.
A new study provides evidence that noncoding RNAs and interactions between noncoding genes play a much greater role in human cancer than was previously understood.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.- Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 174 mg and 348 mg strength bupropion hydrobromide tablets prior to the expiration of patents owned by Biovail. Watson's 174 mg and 348 mg strength bupropion hydrobromide tablet products are generic versions of Biovail's Aplenzin™ ER, which is indicated for major depressive disorder.
BioScrip, Inc. today announced third quarter net income of $5.7 million, or $0.14 per diluted share, on revenues of $333.5 million. These results compare to net income of $1.4 million, or $0.04 per share, on revenues of $359.4 million for the third quarter of 2008. Third quarter 2009 EBITDAO was $8.9 million compared to $5.3 million for the same period a year ago.
› Verified 2 days ago
| Entity Name | Timberridge Imaging Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669460473 PECOS PAC ID: 9436049863 Enrollment ID: O20040318000633 |
News Archive
A webcam language interpretation service is helping three Arizona hospitals better serve Spanish-speaking patients in their emergency departments, the East Valley & Scottsdale Tribune reports. The Iasis Healthcare hospitals had relied on telephone interpretation services before implementing the new webcam system.
A new study provides evidence that noncoding RNAs and interactions between noncoding genes play a much greater role in human cancer than was previously understood.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.- Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 174 mg and 348 mg strength bupropion hydrobromide tablets prior to the expiration of patents owned by Biovail. Watson's 174 mg and 348 mg strength bupropion hydrobromide tablet products are generic versions of Biovail's Aplenzin™ ER, which is indicated for major depressive disorder.
BioScrip, Inc. today announced third quarter net income of $5.7 million, or $0.14 per diluted share, on revenues of $333.5 million. These results compare to net income of $1.4 million, or $0.04 per share, on revenues of $359.4 million for the third quarter of 2008. Third quarter 2009 EBITDAO was $8.9 million compared to $5.3 million for the same period a year ago.
› Verified 2 days ago
| Entity Name | Medical Imaging Center Of Ocala Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669469045 PECOS PAC ID: 0345130787 Enrollment ID: O20040318000671 |
News Archive
A webcam language interpretation service is helping three Arizona hospitals better serve Spanish-speaking patients in their emergency departments, the East Valley & Scottsdale Tribune reports. The Iasis Healthcare hospitals had relied on telephone interpretation services before implementing the new webcam system.
A new study provides evidence that noncoding RNAs and interactions between noncoding genes play a much greater role in human cancer than was previously understood.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.- Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 174 mg and 348 mg strength bupropion hydrobromide tablets prior to the expiration of patents owned by Biovail. Watson's 174 mg and 348 mg strength bupropion hydrobromide tablet products are generic versions of Biovail's Aplenzin™ ER, which is indicated for major depressive disorder.
BioScrip, Inc. today announced third quarter net income of $5.7 million, or $0.14 per diluted share, on revenues of $333.5 million. These results compare to net income of $1.4 million, or $0.04 per share, on revenues of $359.4 million for the third quarter of 2008. Third quarter 2009 EBITDAO was $8.9 million compared to $5.3 million for the same period a year ago.
› Verified 2 days ago
| Entity Name | Radiology Imaging Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063400729 PECOS PAC ID: 2466342803 Enrollment ID: O20040318000719 |
News Archive
A webcam language interpretation service is helping three Arizona hospitals better serve Spanish-speaking patients in their emergency departments, the East Valley & Scottsdale Tribune reports. The Iasis Healthcare hospitals had relied on telephone interpretation services before implementing the new webcam system.
A new study provides evidence that noncoding RNAs and interactions between noncoding genes play a much greater role in human cancer than was previously understood.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.- Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 174 mg and 348 mg strength bupropion hydrobromide tablets prior to the expiration of patents owned by Biovail. Watson's 174 mg and 348 mg strength bupropion hydrobromide tablet products are generic versions of Biovail's Aplenzin™ ER, which is indicated for major depressive disorder.
BioScrip, Inc. today announced third quarter net income of $5.7 million, or $0.14 per diluted share, on revenues of $333.5 million. These results compare to net income of $1.4 million, or $0.04 per share, on revenues of $359.4 million for the third quarter of 2008. Third quarter 2009 EBITDAO was $8.9 million compared to $5.3 million for the same period a year ago.
› Verified 2 days ago
| Entity Name | East Central Florida Outpatient Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245271675 PECOS PAC ID: 9830175199 Enrollment ID: O20040628000215 |
News Archive
A webcam language interpretation service is helping three Arizona hospitals better serve Spanish-speaking patients in their emergency departments, the East Valley & Scottsdale Tribune reports. The Iasis Healthcare hospitals had relied on telephone interpretation services before implementing the new webcam system.
A new study provides evidence that noncoding RNAs and interactions between noncoding genes play a much greater role in human cancer than was previously understood.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.- Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 174 mg and 348 mg strength bupropion hydrobromide tablets prior to the expiration of patents owned by Biovail. Watson's 174 mg and 348 mg strength bupropion hydrobromide tablet products are generic versions of Biovail's Aplenzin™ ER, which is indicated for major depressive disorder.
BioScrip, Inc. today announced third quarter net income of $5.7 million, or $0.14 per diluted share, on revenues of $333.5 million. These results compare to net income of $1.4 million, or $0.04 per share, on revenues of $359.4 million for the third quarter of 2008. Third quarter 2009 EBITDAO was $8.9 million compared to $5.3 million for the same period a year ago.
› Verified 2 days ago
| Entity Name | Inverness Medical Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093763591 PECOS PAC ID: 3870590672 Enrollment ID: O20061108000195 |
News Archive
A webcam language interpretation service is helping three Arizona hospitals better serve Spanish-speaking patients in their emergency departments, the East Valley & Scottsdale Tribune reports. The Iasis Healthcare hospitals had relied on telephone interpretation services before implementing the new webcam system.
A new study provides evidence that noncoding RNAs and interactions between noncoding genes play a much greater role in human cancer than was previously understood.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.- Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 174 mg and 348 mg strength bupropion hydrobromide tablets prior to the expiration of patents owned by Biovail. Watson's 174 mg and 348 mg strength bupropion hydrobromide tablet products are generic versions of Biovail's Aplenzin™ ER, which is indicated for major depressive disorder.
BioScrip, Inc. today announced third quarter net income of $5.7 million, or $0.14 per diluted share, on revenues of $333.5 million. These results compare to net income of $1.4 million, or $0.04 per share, on revenues of $359.4 million for the third quarter of 2008. Third quarter 2009 EBITDAO was $8.9 million compared to $5.3 million for the same period a year ago.
› Verified 2 days ago
| Entity Name | Ocala Health Imaging Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023318060 PECOS PAC ID: 8224217179 Enrollment ID: O20110124001037 |
News Archive
A webcam language interpretation service is helping three Arizona hospitals better serve Spanish-speaking patients in their emergency departments, the East Valley & Scottsdale Tribune reports. The Iasis Healthcare hospitals had relied on telephone interpretation services before implementing the new webcam system.
A new study provides evidence that noncoding RNAs and interactions between noncoding genes play a much greater role in human cancer than was previously understood.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.- Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 174 mg and 348 mg strength bupropion hydrobromide tablets prior to the expiration of patents owned by Biovail. Watson's 174 mg and 348 mg strength bupropion hydrobromide tablet products are generic versions of Biovail's Aplenzin™ ER, which is indicated for major depressive disorder.
BioScrip, Inc. today announced third quarter net income of $5.7 million, or $0.14 per diluted share, on revenues of $333.5 million. These results compare to net income of $1.4 million, or $0.04 per share, on revenues of $359.4 million for the third quarter of 2008. Third quarter 2009 EBITDAO was $8.9 million compared to $5.3 million for the same period a year ago.
› Verified 2 days ago
| Entity Name | St Thomas Radiology Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659385011 PECOS PAC ID: 0042235137 Enrollment ID: O20201204000710 |
News Archive
A webcam language interpretation service is helping three Arizona hospitals better serve Spanish-speaking patients in their emergency departments, the East Valley & Scottsdale Tribune reports. The Iasis Healthcare hospitals had relied on telephone interpretation services before implementing the new webcam system.
A new study provides evidence that noncoding RNAs and interactions between noncoding genes play a much greater role in human cancer than was previously understood.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.- Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 174 mg and 348 mg strength bupropion hydrobromide tablets prior to the expiration of patents owned by Biovail. Watson's 174 mg and 348 mg strength bupropion hydrobromide tablet products are generic versions of Biovail's Aplenzin™ ER, which is indicated for major depressive disorder.
BioScrip, Inc. today announced third quarter net income of $5.7 million, or $0.14 per diluted share, on revenues of $333.5 million. These results compare to net income of $1.4 million, or $0.04 per share, on revenues of $359.4 million for the third quarter of 2008. Third quarter 2009 EBITDAO was $8.9 million compared to $5.3 million for the same period a year ago.
› Verified 2 days ago
| Entity Name | Community Imaging Alliance Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194466854 PECOS PAC ID: 6305227190 Enrollment ID: O20220726001435 |
News Archive
A webcam language interpretation service is helping three Arizona hospitals better serve Spanish-speaking patients in their emergency departments, the East Valley & Scottsdale Tribune reports. The Iasis Healthcare hospitals had relied on telephone interpretation services before implementing the new webcam system.
A new study provides evidence that noncoding RNAs and interactions between noncoding genes play a much greater role in human cancer than was previously understood.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.- Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 174 mg and 348 mg strength bupropion hydrobromide tablets prior to the expiration of patents owned by Biovail. Watson's 174 mg and 348 mg strength bupropion hydrobromide tablet products are generic versions of Biovail's Aplenzin™ ER, which is indicated for major depressive disorder.
BioScrip, Inc. today announced third quarter net income of $5.7 million, or $0.14 per diluted share, on revenues of $333.5 million. These results compare to net income of $1.4 million, or $0.04 per share, on revenues of $359.4 million for the third quarter of 2008. Third quarter 2009 EBITDAO was $8.9 million compared to $5.3 million for the same period a year ago.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Timothy R Jones, MD 1673 Mason Ave, Suite #305, Daytona Beach, FL 32117-5515 Ph: (386) 274-7118 | Dr Timothy R Jones, MD 1673 Mason Ave, Suite #305, Daytona Beach, FL 32117-5515 Ph: (386) 274-7118 |
News Archive
A webcam language interpretation service is helping three Arizona hospitals better serve Spanish-speaking patients in their emergency departments, the East Valley & Scottsdale Tribune reports. The Iasis Healthcare hospitals had relied on telephone interpretation services before implementing the new webcam system.
A new study provides evidence that noncoding RNAs and interactions between noncoding genes play a much greater role in human cancer than was previously understood.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.- Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 174 mg and 348 mg strength bupropion hydrobromide tablets prior to the expiration of patents owned by Biovail. Watson's 174 mg and 348 mg strength bupropion hydrobromide tablet products are generic versions of Biovail's Aplenzin™ ER, which is indicated for major depressive disorder.
BioScrip, Inc. today announced third quarter net income of $5.7 million, or $0.14 per diluted share, on revenues of $333.5 million. These results compare to net income of $1.4 million, or $0.04 per share, on revenues of $359.4 million for the third quarter of 2008. Third quarter 2009 EBITDAO was $8.9 million compared to $5.3 million for the same period a year ago.
› Verified 2 days ago
Dr. John William Gianini, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1673 Mason Ave, Suite 305, Daytona Beach, FL 32117 Phone: 386-274-7118 Fax: 386-274-6173 | |
Joseph M Kaminski, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1620 Mason Ave Ste E, Daytona Beach, FL 32117 Phone: 386-506-5115 Fax: 386-506-5112 | |
Dr. Scott D Klioze, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1673 Mason Ave, Suite # 305, Daytona Beach, FL 32117 Phone: 386-274-7118 Fax: 386-274-6173 | |
Dr. John E Agles, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1673 Mason Ave, Suite # 305, Daytona Beach, FL 32117 Phone: 386-274-7118 Fax: 386-274-6173 | |
Dr. John C Tonkin, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1673 Mason Ave, Suite# 305, Daytona Beach, FL 32117 Phone: 386-274-7118 Fax: 386-274-6173 | |
Dr. David B Turetsky, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1673 Mason Ave, Suite # 305, Daytona Beach, FL 32117 Phone: 386-274-7118 Fax: 386-274-6173 | |
Dr. Charles David Hechtman, MD, PH.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 303 N Clyde Morris Blvd, Daytona Beach, FL 32114 Phone: 386-254-4210 |